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There is an urgent need to understand the risk and protective factors associated with 
poor mental wellbeing of UK HCW working during the COVID-19 pandemic. 
 
Method 
Shortly after the April 2020 UK COVID-19 peak 2,773 HCWs completed a survey 
containing measures of anxiety, depression, PTSD, stress, as well as questions 
around potential predictors such as roles, COVID-19 risk perception and workplace-
related factors. Respondents were classified as high or low symptomatic on each scale 
and logistic regression revealed factors associated with severe psychiatric symptoms. 
Change in wellbeing from pre to during COVID-19 was also quantified.  
 
Results 
Nearly a third of HCWs reported the most severe levels of anxiety and depression, 
and the number reporting very high symptoms was more than quadruple that pre-
COVID-19. Several controllable factors were associated with the most severe level of 
psychiatric symptoms: insufficient PPE availability, workplace preparation, training 
and communication, and higher workload. Being female, ‘frontline’, previous 
psychiatric diagnoses, traumatic events, and being an allied HCW or manager were 
also significantly associated with severe psychiatric symptoms. Sharing stress, 
resilience, and ethical support for treatment decisions were significantly associated 
with low psychiatric symptoms. Frontline workers showed greater worsening of mental 
health compared to non-frontline HCWs.  
 
Conclusions  
Together, poor mental wellbeing was prevalent during the COVID-19 response and 
controllable factors associated with severe psychiatric symptoms are available to be 
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targeted to reduce the detrimental impact of COVID-19 and other pandemics on HCW 
mental health. 
Introduction 
The rapid transmission rates and clinical severity of COVID-19 on patient health have 
brought global national health systems and their healthcare workers (HCWs) under 
considerable pressure. Whilst HCWs already experience high levels of job-related 
stress (1) and are at risk of poor psychological wellbeing (2), their highly-demanding 
work (3) will be exacerbated during a pandemic increasing risk of ‘burnout’ (4), poorer 
quality of care (5) and risk of developing other mental health problems (2). During 
epidemics, it has been shown that worse HCW mental health is associated with 
contact with infected people; redeployment; inadequate training; existing mental 
health disorders (6,7) and ‘moral injury’ (distress from being unable to provide 
treatment) (8); while better support, protective equipment, clear communication (6,9) 
and resilience (10) may protect mental health. The COVID-19 pandemic presents 
additional novel and specific challenges and risks to HCW mental wellbeing as they 
carry out their roles and responsibilities.  
 
An initial study conducted in China early on in the COVID-19 pandemic found that 
HCW working during COVID-19 experienced a high prevalence of severe depression, 
anxiety and PTSD. Those were female, young, ‘frontline’, and working in Wuhan, were 
factors most associated with severe psychiatric symptoms (11). Since then, COVID-
19 has also had a profound effect on the UK health system, and while some recent 
work has shown there is a significant impact on UK healthcare workers mental 
wellbeing (12–14), there is a need for additional and more comprehensive research to 
fully characterise the impact of the COVID-19 pandemic - and this objective warrants 
urgent attention (15). Identifying factors associated with working during COVID-19 
which are detrimental to mental health can provide targets by which their impact on 
HCW mental well-being may be mediated. This may, in turn, help maintain the efficacy 
of healthcare systems.  
 
Research to date has largely been in smaller HCW cohorts, outside the UK, and not 
included consideration of COVID-19-relevant risk factors, or only a limited range 
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potential risk factors, which may affect HCW mental health. This study aimed to 
address these shortfalls and provide a comprehensive examination of the mental 
health of a large cohort of UK HCW and how it has been affected by the COVID-19 
pandemic by: 1) quantifying the prevalence of severe psychiatric symptoms in UK 
HCW shortly after the initial UK COVID-19 peak; 2) identifying factors significantly 
associated with these symptoms; 3) quantifying how mental health changed compared 
to before COVID-19; 4) quantifying HCW worries; and 5) revealing whether frontline, 
London-based, ethnic minorities, HCW, and those making challenging moral/medical 
decisions, had more severe psychiatric symptoms compared to their counterparts.  
Method 
Design 
We report cross-sectional baseline data acquired shortly after the peak of the COVID-
19 pandemic in the UK (between 22ndApril and 10th May 2020 inclusive (see 
supplementary materials S1)) from an on-going, survey-based, longitudinal cohort 
study. The authors assert that all procedures contributing to this work comply with the 
ethical standards of the relevant national and institutional committees on human 
experimentation and with the Helsinki Declaration of 1975, as revised in 2008. All 
procedures involving human subjects/patients were approved by the University of 
Roehampton Ethics Committee (REF: PSYCH 20/361) and the UK Health Research 
Authority. 
 
Participants and survey dissemination 
 
An online web-based survey, outlined below, was open to all UK HCWs to complete. 
Specific survey dissemination was done as follows (see also supplementary materials 
S2). The study synopsis survey and weblink was shared through clinical networks, 
social media and a study webpage and all NHS R&D departments in the UK were 
contacted and asked to disseminate the survey synopsis and weblink to staff. Within 
the planned study period, 52 NHS services (see supplementary materials S2) 
specifically agreed to promote the study to staff either through direct circular emails, 
staff intranet, or both. Additionally, text in the synopsis and survey encouraged 
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respondents to share the survey link with other healthcare professionals. The study 
invitation text strongly encouraged all HCW to take part even if they did not feel 
affected by the impact of COVID-19. Eligible respondents were UK-based HCWs who 
were 18 years or older. Written informed consent was obtained from all subjects.  
 
The survey was implemented on the Qualtrics platform and cross-sectional data on 
the following were collected: 
 
1. Validated mental health scales measuring four symptom domains: The PHQ-9 (16) 
(Patient Health Questionnaire) measures depressive symptoms in the last 2 weeks; 
the GAD-7 (17) (General Anxiety Disorder-7) measures anxiety over the previous 2 
weeks. The 22-item IES-R (18) (Impact of event scale – revised) measures PTSD 
symptoms over the past 7 days; and the PSS (19) (Perceived Stress Scale) measures 
perception of stress over the past month. Only individuals who had experienced a 
stressful or traumatic event related to COVID-19 were administered the IES-R. Also, 
the CD-RISC (Connor-Davidson Resilience Scale)(20) was administered which 
measures resilience.  
 
2. Questions addressing potential factors (see supplementary materials S3) 
associated with psychiatric symptoms were identified using a knowledge-based 
approach built on scientific literature, through focus groups, study team meetings, and 
survey piloting feedback. The items included could be clustered within the following 
themes: (a) Demographics and roles including working on the ‘frontline’ (directly 
engaged in diagnosing, treating, or caring for patients); (b) Workplace readiness and 
preparation; (c) Risk management including Personal Protective Equipment (PPE); (d) 
Experience of traumatic and stressful events; (e) Protective: being able to share stress 
at work.  
 
3. Respondents also quantified their level of current worry on items concerning their 
work, personal lives and COVID-19 using a 10-point Likert scale (see supplementary 
S3 section G and S10).  
 
 6 
4. Additionally, ratings were made for items concerning wellbeing, worries and views 
about work (on a 5-point Likert scale) during COVID-19 (at survey completion) and pre 
COVID-19 i.e. retrospectively. These items were again selected from focus groups, 
study team meetings, and survey piloting feedback and included anxiety, depression, 
and stress items (see supplementary materials S3 (section F) and table 5). 
Data analysis 
Analyses were conducted to (i) determine the prevalence of high levels of psychiatric 
symptoms, (ii) reveal the factors positively or negatively associated with high levels of 
psychiatric symptoms, and (iii) quantify change in mental health from before COVID, 
and to investigate group differences in psychiatric symptoms.  
 
Prevalence of high psychiatric symptoms 
 
‘High symptoms’ of depression and anxiety were determined by individuals scoring 
≥10 on the PHQ and GAD scales (‘moderate’ and ‘severe’ symptoms). Severe stress 
was classified by a PSS score ≥24 (upper quartile) and an IES-R score of ≥26 was 
used to classify high PTSD symptoms. 
 
Factors associated with high psychiatric symptoms 
 
The relationship between ‘high’ levels of each symptom and potential predictive 
factors was determined with chi-square analyses. Stepwise multivariable logistic 
regression analyses for each symptom domain (‘high symptoms’ vs not) were then 
performed and included the factors that were significant in chi-square analyses (0.05 
significance level to enter / stay in the model). 
 
Change in mental health and group differences 
 
Repeated-measures ANOVA were used to quantify change in wellbeing from pre to 
during COVID-19 for the whole cohort, and to examine between-group differences. 
Stratified analyses were also conducted (i) to reveal whether frontline (FL) vs non-
frontline (NFL), ethnic minorities (see table 1 for ethnicity descriptions; vs non- ethnic 
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minorities) workers, and those making challenging medical decisions (vs not) had 
higher psychiatric symptoms than their counterparts; and (ii) to compare level of 
current worries between FL and NFL. Partial η2 was used as a measure of the effect 
size for repeated-measures ANOVA. Cut-offs for small, medium and large effect sizes 
were .0099, .0588, and .1379, respectively (21,22). Analyses were conducted in SAS 
9.4 (SAS Institute Inc.) and SPSS v25 (IBM Corp., Armonk, N.Y., USA).  
Results  
Participant demographics and roles  
3379 participants consented. Non-HCW and those who completed <70% of the survey 
were excluded leaving 2773 respondents (see table 1 for main descriptive statistics 
and supplementary tables S4-7).  
 
---- Table 1 here ---- 
 
Prevalence of high psychiatric symptoms 
Table 2 shows cohort psychiatric symptoms. 28.1% (374) were above the cut-off for 
high depression, 33.1% (919) for high anxiety; and 27.5% (750) were in the top quartile 
for stress (see table). 60.6% (1681) had experienced a stressful or traumatic event 
related to COVID-19 and 14.6% (404) were above the cut-off for high PTSD 
symptoms.    
---- Table 2 here ---- 
Predictive models of high psychiatric symptoms 
All stepwise multivariate logistic regression models converged with no significant 
collinearity of factors, or residual data due to missingness. All models were highly 
significant (likelihood ratio, core, and Wald p<.0001) presenting good fit and high 
prediction capabilities (c score = 0.739 – 0.82). Significant factors retained in each 
model of symptoms with odds ratios are shown in table 3 and reported below. 
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Frequency distributions are shown in table 4; chi-square summaries are reported in 
supplementary materials S8. 
 
---- Table 3 here ---- 
 




As shown in table 3, high anxiety was significantly associated with being female, all 
non-doctor roles (vs doctor), working outside London, being frontline, and having a 
mental health diagnosis. Friends or family dying from COVID-19, patients asking if 
they are going to die, and performing resuscitation were also associated with high 
anxiety, as were insufficient training, extra workload, insufficient information and 
thinking not enough is currently being done to reduce risk. 
 
PTSD symptoms  
 
All non-doctor (vs doctor) roles - particularly being a manager, and being FL, being 
from an ethnic minority, and existing mental health conditions were significantly 
associated with high PTSD symptoms, as did experience of all traumatic and stressful 
events except aftercare of the deceased. High PTSD symptoms were also significantly 
associated with pressure to re-use PPE; insufficient information; perception that not 




High depression was significantly associated with being female, all non-doctor roles 
(vs doctor), working outside London, and having a mental health diagnosis. Those 
experiencing friends or family dying, patients asking them if they are going to die, and 
performing aftercare for the deceased were significantly more likely to be in the high 
depression group. Extra workload, pressure to work without PPE, insufficient 
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information and perception that not enough had been done to reduce risk were also 




Being female, older (55-64 years vs <25), all non-doctor roles (vs doctor), working on 
the frontline, and having a mental health diagnosis were associated with significantly 
increased likelihood of being in the high stress group; as were insufficient information, 
pressure to work without PPE, >20% of team members off sick, and perception that 
not enough had been done to reduce risk.  
 
Factors associated with having lower psychiatric symptoms 
 
Being able to share stress at work and resilience were associated with significantly 
lower likelihood of being in the high anxiety, stress and depression groups - though 
there was no significant association with PTSD symptoms.  
 
Change from pre-COVID-19 to during COVID-19. 
 
Across the cohort, every mental health symptom, concern, and work-related issue was 
rated as significantly worse during COVID-19 compared to pre-COVID-19 - most to a 
highly significant level with very high effect sizes (see supplementary material S9). 
HCWs being worried about their family health showed the greatest (negative) change.  
 
FLs rated themselves lower than NFLs pre-COVID in terms of: stress, wanting to quit, 
needing psychological help, worrying about NHS resources and their own health 
concerns - however time x group interaction effects revealed that FLs reported a 
significantly greater worsening of these from pre- to during COVID-19 than NFLs.  For 
the other negative factors FLs ratings were not significantly different to NFLs pre-
COVID-19 but FLs reported significantly greater worsening from pre to during COVID-




The anxiety, low mood and stress items mirror the main symptom outcome scores 
(anxiety-GAD, low mood-PHQ, and stress-PSS), and in concrete terms there was a 
considerable shift in the distribution of severity of these symptoms during COVID-19 
(shown in table 5): pre-COVID 85.9% of HCWs reported ‘no’ or ‘very little’ feeling of 
low mood but this diminished to only 55.6% during the COVID-19 response while the 
5.2% reporting ‘a lot’ or ‘very’ pre-COVID-19 rose to 21.6% - more than a quadrupling. 
This shift in frequency distribution towards worse mood across the cohort was highly 
significant (χ2=1101, p<.0001). A similar pattern was evident for ‘feeling anxious’: the 
number of HCWs in the two most severe levels rose from 7.8% to 35.8% – and the 
number experiencing the most severe levels of ‘feeling stressed’ rose from 10.7% to 
45.7%. These shifts in frequency distribution towards worse anxiety (χ2=962.8, 
p<.0001) and worse stress across the cohort were highly significant (χ2=623.7, 
p<.0001). 
 
Every positive factor also significantly worsened across the cohort from pre to during 
COVID-19 (see supplementary material S9). Pre-COVID-19, FLs felt more resilient, 
more ‘positive’ and tech confident, and that their team was more effective than NFLs. 
However, FLs had significantly greater declines in feeling resilient, as well as 
remaining positive, and feeling supported compared to NFL.  
 
 ---- Figure 1 here ----  
 
Frontline, London and ethnic minority workers 
 
FLs were significantly more likely to be more depressed, anxious, have high PTSD 
symptoms and be more stressed than NFL (all p<.0001). Working in London was 
associated with lower risk of depression (p<.01) and anxiety (p<.0005) than outside 
London (though no difference in stress or PTSD). Ethnic minority status (N=342) was 
significantly associated with greater risk of high PTSD symptoms (OR=1.52), but not 
high anxiety, stress, or depression.  
 
Post-hoc analyses were conducted to explore ethnic minority experiences further. 
Physically 'at-risk’ ethnic minority individuals (N=85) did not have higher psychiatric 
 11 
symptoms than ethnic minority individuals not 'at-risk’ (N=257), nor compared to non- 
ethnic minority individuals physically ‘at risk’ (N=593) (all ps>0.45). Ethnic minority 
individuals were, however, significantly more worried about contracting COVID-19 at 
work (mean(sd)=3.09(1.08) vs non-ethnic minority individuals mean(sd) = 2.67(1.07); 
t(2754)=6.84, p<.0001); being uncertain of having COVID-19 (mean(sd)=2.77(1.16) 
vs non-ethnic minority mean(sd)=2.21(1.09); t(2754)=8.93, p<.001); getting ill or dying 
from COVID-19 (mean(sd)=2.2(1.12) vs non-ethnic minority mean(sd)=1.88 (1.19), 
t(2754)=4.74, p<.001) and lack of PPE (mean(sd)=2.86 (1.14) vs non-ethnic minority 
mean(sd) = 2.39(1.12), t(2754)=7.29, p<.001).  
 
Medical decision-making  
 
11.1% (307) of respondents were in a position to make decisions about whether 
patients received treatment and 17.9% (53) had denied treatment to a patient (see 
supplementary materials S7). They reported significantly more anxiety (but not 
depression, PTSD symptoms (though strong trend), or stress (though strong trend)) 
than those (N=39) who had not denied treatment (GAD mean=8.00 (5.94) vs 5.46 
(5.19), t(90)=2.13, p<.05). Those with support of an ethics panel in decision-making 
(58.0% (178)) were significantly less stressed (PSS mean=16.98 (8.1) vs mean=19.06 
(7.33), t(302)=2.29, p<.01) but were not significantly less depressed, anxious, nor had 




Across the cohort, worry was greatest for family and friends becoming ill or dying from 
COVID-19 followed by worries that they will infect them (see supplementary table S10 
for full list); and lowest for their own mental health and about poor workplace 
management. FL were significantly more worried than NFL for all concerns (all p<.001 
except ‘ability to support others’ which was also significantly higher though at a higher 
threshold (p<0.05). 
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Discussion 
To our knowledge this is the first study examining the impact of COVID-19 on the 
mental health of HCWs in the UK. A significant proportion reported high depression 
(28%), high anxiety (33%), and high COVID-19-related PTSD symptoms (15%). 
Across the cohort, mental health indicators had significantly deteriorated compared to 
before COVID. Analyses revealed a set of fixed (demographic and role-related) and a 
separate set of controllable factors which were significantly associated with high levels 
of psychiatric symptoms in HCW. 
 
The fixed risk factors for high psychiatric symptoms were being female, all roles 
compared to doctor, working on the ‘frontline’, and having an existing mental disorder. 
Being single was associated with high depression and being younger to stress. While 
some of these components have been identified in previous pandemics(6,9) and 
recent research of much smaller cohorts outside the UK(11,23–25) the present study 
expands significantly on this work in several ways in terms of sample size, 
comprehensive examination of risk factors beyond demographics and roles, and 
scope of findings. We show, that allied HCW, and particularly managers, were at 
significantly increased risk of high symptoms. Managers, in particular, were 5.2 times 
more likely to report high PTSD symptoms - likely due to additional pressures and the 
rapid changes COVID-19 brings to their healthcare settings as well as increased threat 
to patients, staff and themselves. Nurses were significantly more likely to be in high 
symptom group compared doctors which is mostly consistent with evidence from 
COVID-19, and other, pandemics ((6,7) however there is some evidence of doctors 
having greater psychiatric symptoms compared to other HCWs ((6,7,24). Differences 
in healthcare settings, HCW roles, and national health systems across countries, as 
well as their COVID-19 response, may account for some of the differential effects 
reported from studies from different countries. This suggests the need for additional 
support for personnel in these roles. 
Importantly, a cluster of controllable risk factors relating to workplace characteristics 
and role-related activities were also significantly associated with high psychiatric 
symptoms. Pressure to work without PPE, and that risk from COVID-19 could have 
been reduced with better workplace preparation, were significantly associated with 
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high depression. These factors were also associated with high stress along with 
practical issues such as absent team members and lack of sufficient information on 
clinical procedures. The effects of having additional workload were broad –  being 
linked to high anxiety, depression and PTSD symptoms, while insufficient training was 
uniquely associated with high levels of anxiety (also shown after SARS((26)). High 
anxiety and PTSD symptoms were additionally associated with insufficient action 
being taken to reduce risk. There was a further critical role of a lack of sufficient 
information on COVID-19 clinical practice - being linked to high symptoms in all 
domains.  
 
Critically then, a number of preventable workplace factors relating to perception of 
personal risk specifically increases the likelihood of having high PTSD symptoms: 
pressure to re-use PPE and failure of the workplace to reduce risk through preparation. 
A strong link between risk perception and PTSD has been reported previously during 
SARS(26–30). As subjective appraisal of threat may contribute more to PTSD 
development than objective trauma severity (31) a sense of persistent danger to the 
self may catalyse the development of PTSD symptoms. This also highlights that 
perception of risk goes beyond PPE availability and includes multiple systemic and 
organisational components within healthcare settings. As a longer or repeated 
exposure (see)(26)(32) raises risk of PTSD, more adequate PPE and workplace 
preparation may mitigate future development of PTSD. It is indeed noteworthy that 
over half of respondents stated that more PPE would reduce their anxiety. 
 
Unlike an earlier study from China(11), an epicentre effect was not apparent. Working 
in London was associated with lower risk of anxiety and depression. While London 
workers were significantly less female, less likely to be pressured to reuse PPE, or 
expect to get severely ill (each linked to lower risk), they also experienced a number 
of risk factors. These effects could be due to better-resourced healthcare settings, 
being more accustomed to stress from city living, or that Wuhan was the first global 
city experiencing a new, fatal virus.  
Other factors that were expected to be associated with psychiatric symptoms were not 
observed. Quarantining of HCW, for example, was not retained as a significant factor 
in any outcome model despite holding significant independent relationships with 
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psychiatric symptoms (see supplementary materials S8). At the time the survey was 
done, UK HCW were required to self-isolate for 7 days if they had possible symptoms 
or 14 days if exposed to someone known to have COVID-19. While an association 
was expected, Bell & Wade (7) report mixed evidence of a relationship between 
quarantine and psychological outcomes, while Kiseley et al. (6) report that it was 
duration of self-isolation and prolonged quarantine which raised risk. It may then be 
that this duration of quarantine was too short to have a notable impact on mental 
health. Alternatively, a shorter quarantine may have even been restful and improved 
mental health in some individuals (as Chong et al. (33) report in relation to SARS), or 
it may simply be that quarantining does not account for sufficient unique variance in 
psychiatric outcomes compared to, for example, witnessing traumatic events, or lack 
of safety equipment.  
Unsurprisingly, traumatic events predicted high symptom scores, particularly PTSD 
symptoms. Personal loss and patients asking if they were going to die were 
significantly associated with high symptoms of PTSD, anxiety and depression. Having 
colleagues with, or dying from, COVID-19 also significantly increased the likelihood of 
being in the high PTSD symptoms group but this was greater with respect to friends 
or family dying. A peer who contracts or dies from COVID may be more indicative of 
an on-going threat of danger to the self. Experiences where death is evident (patients 
dying and delivering bad news) were also associated with high PTSD symptoms (also 
seen following SARS)(27). Together, personal threat was associated with having high 
PTSD symptoms while the impaired readiness to work effectively in response to 
COVID-19 was linked to high anxiety - perhaps due to these being preventable. Lastly, 
aftercare for the deceased was uniquely linked to depression; performing resuscitation 
was associated with high anxiety and PTSD symptoms; and practical issues with high 
stress. 
 
Moral injury may contribute to the development of psychiatric symptoms(8). Here, 
HCWs who had denied treatment to patients were more anxious than those who had 
not, while support from an ethics panel was associated with lower stress highlighting 
the protective effects of shared decision-making on HCW mental wellbeing. The higher 
risk to managers may be due to such moral injury and the inability to adequately treat 
patients or protect staff. 
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Evidence that ethnic minority individuals are at elevated physical risk of COVID-19 
was first published near the survey start date(34). While ethnic minority HCW were 
more likely to report high PTSD symptoms this was not accompanied by a significantly 
greater risk of high anxiety, depression or stress. Being ‘physically at high risk’ of 
COVID-19 was not associated with high psychiatric symptoms, but greater worry 
about self-protection. Elevated prevalence of PTSD in ethnic minority individuals has 
previously been reported(35) and is associated with ‘additional life stress’(36). While 
more research on PTSD in ethnic minority individuals should be done, this finding may 
reflect the same sense of sustained threat. 
 
Across the cohort, all wellbeing indicators significantly worsened during COVID-19 
compared to before. The proportion of the cohort who rated their psychiatric symptoms 
(anxiety, low mood, stress) at the most severe levels increased by 4 to 4.5 times during 
the COVID-19 response compared to pre-COVID levels. FLs had significantly greater 
worries than NFL and were more also likely to be more depressed, anxious, and 
stressed than NFL - and were 2.1 times as likely to have high PTSD symptoms - likely 
due to the traumatic and stressful duties they perform, as well as their concerns about 
risk, PPE access and preparation.  
Resilience and the ability to share stress at work were significantly associated with 
having low symptoms except PTSD. Inadequate support has previously been shown 
to raise the risk of psychiatric morbidity in FL(6,7,27). Contrastingly however, scores 
on the “I need psychological help?” item were low as were HCW worries about their 
‘own mental health’. Staff may indeed prefer practical help such as more rest or PPE 
to psychological support(37). Resilience training may improve resistance to poor 
wellbeing, although this has been insufficiently researched in healthcare settings. 
PTSD symptoms may not be attenuated by resilience perhaps due to the more 
automatic and physiological, rather than cognitive, nature of these symptoms. 
The study has several strengths and limitations. We recruited a large sample by 
COVID-study standards (though only a 19.8% [52/262] response rate within all NHS 
services), near the peak of the first COVID-19 UK outbreak, and the study provides 
the most comprehensive picture to date of the negative psychological impact of HCW 
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to COVID-19 in the UK and its associated factors. Participation in online surveys 
involves self-selection and respondents may not be fully representative. However, this 
approach permitted a rapid response around a critical period very close to the COVID-
19 peak. Nonetheless, these findings should be viewed with caution as they may not 
be generalizable. The survey was de facto open to all HCW in the UK and the very 
large sample size reflected a wide geographical coverage of the UK. That the sample 
characteristics were similar to the wider NHS workforce in terms of female:male ratio 
(85%, NHS=77%) and proportion from ethnic minorities  (13% vs NHS 19%) indicate 
that the data are broadly representative. The survey was launched 4 weeks after the 
UK national ‘lockdown’ began and psychiatric presentation may be affected by 
lockdown as well as due to working during the COVID-19 peak – though these would 
be expected to de facto co-occur. 
Pre-COVID-19 wellbeing scores derived from ratings which may not be fully accurate 
as they were retrospective, however, evidence suggests that ratings of past events in 
depressed individuals are reliable(38). Nonetheless, these findings should be viewed 
with caution as they may not be generalizable. If low mood resulted in more negative 
past ratings(39), this would only increase the effect sizes of worsening suggesting 
these effects are robust. Mood scores indicated that the cohort were not a particularly 
anxious or worrisome group per se and the majority of respondents reported only low 
or mild symptoms of anxiety and depression and low worry levels before COVID-19. 
The frequency of psychiatric disorders was also low and very similar to rates in the 
general population(35), while symptom scale scores and PTSD prevalence were 
similar to comparable studies(6,11). Lastly, the study information also strongly 
encouraged those who felt they “were not be affected by COVID outbreak” to take 
part, so we would “have a complete view of HCW mental health” to prevent recruiting 
a biased cohort of only respondents who felt adversely affected. The scales used were 
self-report and not diagnostic but have strong validity and reliability and are commonly 
used. This survey was cross-sectional but planned follow-up surveys will permit 
longitudinal analysis of effects and relationships. Finally, additional factors not 
examined may have a role in HCW mental health. 
In conclusion, the COVID-19 pandemic has had a discernible and detrimental effect 
on the mental health and well-being of UK HCWs. High symptoms of poor mental 
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health were prevalent, and markers of wellbeing had significantly worsened compared 
to before COVID. A number of fixed and controllable factors were significantly 
associated with poor mental wellbeing, the latter reflecting elevated perception of 
COVID-19 risk and inadequate workplace preparedness. Critically, these findings can 
guide management strategy such as by improving PPE availability, training, 
communication of information, and management of staff absence. These are readily 
amenable targets and may reduce the risk of HCWs developing poor mental health 
during COVID-19, or other pandemics.  
The study also strongly indicates that psychological risk assessments should be 
carried out based on the factors identified. All staff should be monitored for poor mental 
health and those showing high symptoms should be referred to mental health services. 
Employers should improve initiatives for HCWs to share stress particularly those with 
risk factors and those making challenging treatment decisions – or even just offer more 
opportunity to rest that HCWs have been reported to need (37). Bespoke interventions 
could be developed which target these factors, such as role- or duty-specific training. 
Improving resilience, perhaps through training, may also be effective, as may teaching 
more adaptive coping styles - recently shown to be associated with better HCW 
wellbeing during the COVID-19 pandemic (12). Importantly, HCW show only low 
recognition of the importance of their own mental health so awareness of this should 
be raised.  Lastly, working as a HCW during a pandemic can result in long term effects 
on mental health, which may persist for years(40). Attenuating these risks may help 
reduce the possibility of a major mental health crisis in UK healthcare and protect and 
retain HCWs. This is critical to delivery of effective treatment for patients and for 
planning a response to a second wave or future epidemic / pandemic - or in other 
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